
Proceedings Paper
Molecular application of spectral photoacoustic imaging in pancreatic cancer pathologyFormat | Member Price | Non-Member Price |
---|---|---|
$17.00 | $21.00 |
Paper Abstract
Spectral imaging is an advanced photo-acoustic (PA) mode that can discern optical absorption of contrast agent(s) in
the tissue micro-environment. This advancement is made possible by precise control of optical wavelength using a
tunable pulsed laser, ranging from 680-970 nm. Differential optical absorption of blood oxygenation states makes
spectral imaging of hemoglobin ideal to investigate remodeling of the tumor microenvironment- a molecular change
that renders resistance to standard cancer treatment.
Approach: Photo-acoustic imaging was performed on the Vevo® LAZR system (VisualSonics) at 5-20 Hz. Deep
abdominal imaging was accomplished with a LZ250D probe at a center frequency of 21MHz and an axial resolution
of 75 μm. The tumor model was generated in an immune compromised mouse by surgical implantation of primary
patient derived tumors, in the pancreas.
Results: Spectral imaging for oxygen saturation at 750 nm and 850 nm characterized this tumor with a poorly
oxygenated core surrounded by a well oxygenated periphery. Multispectral imaging identified a sub region in the
core with a four-fold signal exclusively at 750 and 800 nm. A co-registered 2D image of this region was shown to be
echogenic and calcification was suspected. Perfusion imaging with contrast enhanced ultrasound using
microbubbles (Vevo MicroMarker® contrast agents, VisualSonics) identified functional vessels towards this sub
region. Histology confirmed calcification and vascularization in the tumor core. Taken together, non-invasive
characterization of the tumor microenvironment using photo-acoustics rendered spectral imaging a sensitive tool to
monitor molecular changes representative of progression of pancreatic cancer that kills within 6 months of
diagnosis.
Paper Details
Date Published: 11 December 2012
PDF: 7 pages
Proc. SPIE 8553, Optics in Health Care and Biomedical Optics V, 855319 (11 December 2012); doi: 10.1117/12.999958
Published in SPIE Proceedings Vol. 8553:
Optics in Health Care and Biomedical Optics V
Qingming Luo; Ying Gu; Xingde D. Li, Editor(s)
PDF: 7 pages
Proc. SPIE 8553, Optics in Health Care and Biomedical Optics V, 855319 (11 December 2012); doi: 10.1117/12.999958
Show Author Affiliations
Minalini Lakshman, VisualSonics Inc. (Canada)
Clinton Hupple, VisualSonics Inc. (Canada)
Ines Lohse, Ontario Cancer Institute (Canada)
Campbell Family Cancer Research Institute (Canada)
Clinton Hupple, VisualSonics Inc. (Canada)
Ines Lohse, Ontario Cancer Institute (Canada)
Campbell Family Cancer Research Institute (Canada)
David Hedley, Ontario Cancer Institute (Canada)
Campbell Family Cancer Research Institute (Canada)
Univ. of Toronto (Canada)
Andrew Needles, VisualSonics Inc. (Canada)
Catherine Theodoropoulos, VisualSonics Inc. (Canada)
Campbell Family Cancer Research Institute (Canada)
Univ. of Toronto (Canada)
Andrew Needles, VisualSonics Inc. (Canada)
Catherine Theodoropoulos, VisualSonics Inc. (Canada)
Published in SPIE Proceedings Vol. 8553:
Optics in Health Care and Biomedical Optics V
Qingming Luo; Ying Gu; Xingde D. Li, Editor(s)
© SPIE. Terms of Use
